GlassScriptPhysician profile
William J Conkright
NPI 1609853191
$15,082.36
in general payments reported to CMS, 2019-2025
56 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,460 · 2020: $1,682 · 2021: $2,537 · 2022: $2,685 · 2023: $2,518 · 2024: $2,516 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,718.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,190.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,652.33 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $1,322.48 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,266.17 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amarin Pharma, INC. | $871.21 | 2019-2022 | |
| Lilly USA, LLC | $771.33 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $656.71 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $556.38 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $489.44 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $336.61 | 2022-2024 | Rexulti |
| Dexcom, INC. | $333.05 | 2021-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $319.92 | 2019-2024 | |
| Astellas Pharma US INC | $275.33 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $220.50 | 2020-2023 | Opdivo, Eliquis |
| Glaxosmithkline, LLC. | $193.49 | 2020-2025 | Trelegy Ellipta |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Conkright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.